Actively Recruiting
NORA-HOME Efficiency And Safety An Ambulatory Multimodal Monitoring Model In Patients With Minor Stroke And Transient Ischemic Attacks
Led by Hospital Universitari Vall d'Hebron Research Institute · Updated on 2026-03-30
250
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
Sponsors
H
Hospital Universitari Vall d'Hebron Research Institute
Lead Sponsor
V
Vall Hebron Insitut Recerca
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are evaluating a Home Hospitalization program called NORAHOME for patients who have had a transient ischemic attack (TIA) or a minor stroke. The study aims to determine if this multimodal home care approach is safe, reduces complications linked to traditional hospital stays, and is more efficient than standard clinical practice. Patients with TIA or minor stroke are at higher risk of stroke recurrence, and current early evaluations often require hospital admission, which can be costly and risky. In this study, patients who come to the Emergency Department with TIA or minor stroke are randomly assigned to either the NORAHOME home hospitalization program or conventional hospital care. The home hospitalization group receives close monitoring and care at home, while the control group undergoes standard hospital admission. The study includes a 3-month follow-up period where outcomes for both groups are compared to assess safety, efficiency, and patient experience. Participants will be monitored for complications such as falls, infections, and stroke recurrence. Assessments include patient-reported health outcomes and experiences, control of vascular risk factors, adherence to treatment, and evaluations of daily living activities. The study also uses diagnostic tests like focused echocardiography and remote cardiac monitoring. Safety and effectiveness are evaluated at 15 days and 3 months, with the total study participation lasting 3 months after enrollment.
CONDITIONS
Brief Title
NORA-HOME: An Ambulatory Multimodal Monitoring Model In Patients With Minor Stroke And Transient Ischemic Attacks
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients presenting to the Emergency Department with symptoms of TIA (complete recovery within <24 hours) or minor stroke (NIHSS 64 5)
- Age >18 years
- Availability of a smartphone for the patient or caregiver
- Family support and/or formal caregiver
- Clinical stability during the last 12 hours in the Emergency Department
- Signed informed consent by the patient and/or family member or legal representative
You will not qualify if you...
- Severe stenosis or symptomatic arterial occlusion requiring admission for potential reperfusion or arterial revascularization treatments
- Pre-existing neurological or psychiatric conditions that may interfere with follow-up and evaluations
- Clinical (terminal condition) or social (language barrier) inability to complete follow-up assessments
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person) at the Emergency Department for initial assessment and consent
Duration - 3 months
Participants randomized to the NORAHOME program receive ambulatory multimodal monitoring and care for their minor stroke or TIA at home.
Ongoing remote monitoring with scheduled in-person visits as needed during the 3-month period
Duration - 3 months
Participants randomized to standard clinical practice receive conventional hospitalization and care for their minor stroke or TIA.
Hospital stay and follow-up visits according to standard clinical practice during the 3-month period
Duration - Up to 3 months post-randomization
Participants in both groups are followed for safety, efficacy, and patient-reported outcomes to compare the two care models after the initial intervention period.
Scheduled follow-up visits and assessments to evaluate safety, recurrence risk, and patient experience
Trial Site Locations
Total: 1 location
1
Vall Hebron University Hospital
Barcelona, Spain, 08035
Actively Recruiting
Research Team
M
Marian Muchada Lopez, MD, PHD
M
Marta Rubiera del Fueyo, MD, PhD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here